Would not chase the #US focused #generic #pharma #stocks higher. They are at best hiding places with low RoEs. Its more like a 1-year tactical trade. That is the view coming in from @rajesh_pherwani of @Valcreate_IM. @_prashantnair &amp; @sonalbhutra speak with him. https://t.co/rvyfnQM2oN